在SARS-CoV2感染的神经学后急性后果中持续自主和免疫学异常

David S Goldstein¹, Yair Mina¹, Brian Walitt¹+11

• ¹From the Autonomic Medicine Section (D.S.G., P.S., J.G., R.I., S.M.), and Infections of the Nervous System Section (Y.M., A.W., B.S.) Clinical Neurosciences Program (CNP), Division of Intramural Research (DIR), National Institute of Neurological Disorders and Stroke (NINDS), NIH, Bethesda, MD; Sackler Faculty of Medicine (Y.M.), Tel Aviv University, Israel; Office of the Clinical Director (B.W., A.N.), and Viral Immunology Section (Y.E.-A., S.J.), DIR, NINDS; and Echocardiography Laboratory (M.-L.N., S.S.), DIR, National Heart, Lung, and Blood Institute, Bethesda, MD.